IONISOS acquired by 3I
Context
Ionisos, a leading European specialist in cold sterilization services, has entered its fifth LBO cycle following its acquisition by 3i Infrastructure. The London-listed investor is deploying �220 million to acquire up to 100% of the company's equity from Ardian Expansion, which had held the asset since 2016. The remaining shares are held by the management team.
IONISOS, which reported an EBITDA margin of [members only] in 2016, is valued in this transaction at an EV/EBITDA multiple of 15x–25x, representing a premium to the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
IONISOS, a specialist in gamma sterilization, ebeam, X-rays and ethylene oxide sterilization, offers its ionizing radiation and EO gas treatment services to professionals in the medical, pharmaceutical, veterinary, cosmetics and agri-food packaging industries.
Ent. Value
€300–700M
Equity Value
[members only]
Multiples
EV / Revenue
Above 6x
EV / EBITDA
15x–25x
EV / EBIT
[members only]
Historical Financials (EUR)
Similar deals in Life Sciences
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 09/2019 | SAGARD | STERIMED | FRANCE | Medical Consumables |
| 08/2019 | PERMIRA | CAMBREX CORPORATION | UNITED STATES | CDMO |
| 07/2019 | PERMIRA | QUOTIENT SCIENCES | UNITED KINGDOM | CDMO |
| 07/2019 | BC PARTNERS | Synthon International | NETHERLANDS | Generics / Labs |
| 05/2019 | ARDIAN | SINTETICA | SWITZERLAND | Pharma & Biotech |
| 04/2019 | ICG / MERIEUX EQUITY PARTNERS | DOC GENERICI | ITALY | Generics / Labs |
| 04/2019 | EURAZEO | D.O.R.C. (DUTCH OPHTHALMIC RESEARCH CENTER) | NETHERLANDS | Medical Devices |
| 12/2018 | MERCK & CO. | ANTELLIQ | FRANCE | Animal Health |
| 11/2018 | ARDIAN | NEOPHARMED GENTILI | ITALY | Generics / Labs |
| 10/2018 | GLANBIA | SLIMFAST | UNITED STATES | Nutrition & Dietary Supplements |
Other operations with 3I
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 06/2026 | 3I | LABORATOIRE NUTERGIA | FRANCE | Nutrition & Dietary Supplements |
| 04/2024 | 3I | CONSTELLATION | FRANCE | Infrastructure & Cloud |
| 06/2023 | 3I | PANELTO FOODS | IRELAND | Bakery / Pastry |
| 09/2021 | 3I | EUROPEAN BAKERY GROUP | NETHERLANDS | Bakery / Pastry |
| 11/2020 | 3I | MPM | UNITED KINGDOM | Pet Care |
| 07/2019 | 3I | EVERNEX | FRANCE | MSP (Managed Services) |
| 11/2016 | 3I / CATHAY CAPITAL | HAVEA | FRANCE | Hygiene & Beauty Brands |
| 11/2013 | 3I | BASIC-FIT | NETHERLANDS | Hospitality |
REFERENCES
Valuation range: EV €300–700M
Revenue range: €25–50M
EBITDA range: €5–25M
EV/Revenue range: Above 6x
EV/EBITDA range: 15x - 25x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of IONISOS by 3I are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Acquirer: 3i